AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-4768733_ITM" title="Facts and information about Manufacturer price changes for brand name drugs widely used by older Americans, 2000-2003.(Data Watch)">Manufacturer price changes for brand name drugs widely used by older Americans, 2000-2003.(Data Watch)</a>
Close
Set up an RSS feed that alerts you when new articles from OB GYN News are available.
Frequently asked questions about RSS feeds
Manufacturer price changes for brand name drugs widely used by older Americans, 2000-2003.(Data Watch)
Manufacturer Price Changes for Brand Name Drugs Widely Used by Older
Americans, 2000-2003
Aver. Annual
Sales Rank Drug Formulation % Chg. in Price
1 Fosamax 70-mg tablet 5.6%
2 Lipitor 10-mg tablet 6.0%
3 Plavix 75-mg tablet (90 pills) 7.8%
4 Lipitor 20-mg tablet 4.8%
5 Prevacid 30-mg capsule DR 5.2%
6 Celebrex 200-mg capsule 4.1%
7 Protonix 40-mg tablet ...
Related articles from newspapers, magazines, journals, and more
For more facts and information, see all results
- European Approval for Roche's New Invirase 500 mg Tablet for the Treatment of...
- Press release article from: PR Newswire Europe May 27, 2005 700+ words
...PRNewswire/ -- - New Invirase 500 mg tablet significantly reduces pill burden for...treatment of HIV infection. The new 500 mg tablet will simplify the dosing regimen for...convenience. "The launch of the 500 mg tablet is a further example of Roche's continuing...
- Salagen 7.5 mg tablet introduced.
- Newspaper article from: Cancer Weekly April 13, 2004 700+ words
...and marketing of the Salagen 7.5 mg tablet (pilocarpine hydrochloride) in the...Administration approved the Salagen 7.5 mg tablet as an alternative strength to the currently marketed Salagen 5 mg tablet. Salagen tablets are indicated for...
- MGI PHARMA Introduces Salagen 7.5 mg Tablet.
- Press release article from: Business Wire March 15, 2004 700+ words
...marketing of the Salagen (R) 7.5 mg tablet (pilocarpine hydrochloride) in the...FDA) approved the Salagen 7.5 mg tablet as an alternative strength to the currently marketed Salagen 5 mg tablet. Salagen tablets are indicated for...
- Barr Initiates Patent Challenge of Fosamax(R) 35 mg Tablet Product; Company...
- Press release article from: PR Newswire December 17, 2001 700+ words
...U.S. Food & Drug Administration (FDA) for the 35 mg tablet product. Fosamax(R) is indicated for the treatment and...successful, our challenge of the patents protecting the Fosamax 35 mg tablet product will provide patients who use this daily therapy with...
- Investigational Formulation of Invirase(R) Granted Priority Review Status by...
- Press release article from: PR Newswire August 17, 2004 700+ words
...New Drug Application (NDA) for a 500 mg tablet formulation of its HIV protease inhibitor...expedited review of the Invirase 500 mg tablet, which could mean faster access for...to further define the role of the 500 mg tablet in the treatment of HIV." Invirase...
- Barr's Generic Prozac 10 mg Tablet Tentatively Approved by FDA; Company Expands...
- Press release article from: PR Newswire September 4, 2001 700+ words
...tablets. The Company expects final approval to market the 10 mg tablet product, as well as Barr's 10 mg capsule product that was...expand our generic Prozac product line with the addition of 10 mg tablet and 10 mg capsule products to our already marketed 20 mg capsule...
- Roche Submits Application to U.S. FDA for New Formulation of Invirase(R); - New...
- Press release article from: PR Newswire June 21, 2004 700+ words
...Drug Administration (FDA) for approval to market a new 500 mg tablet formulation of its HIV protease inhibitor Invirase(R...potency and a well-characterized safety profile." "The 500 mg tablet is another important example of Roche's commitment to the...
- Study Demonstrates New Treatment Option for Patients With Moderately Active...
- News wire article from: Ascribe Higher Education News Service November 1, 2004 700+ words
...to receive 4.8 grams daily (g/day) of mesalamine (800 mg tablet) or 2.4 g/day mesalamine (400 mg Asacol tablet) for...University of Chicago Pritzker School of Medicine. "The 800 mg tablet in this study enabled patients to receive 4.8 g/day of...
